美國腎臟去神經導管市場規模、佔有率和趨勢分析報告：按產品、最終用途和細分市場預測，2025 年至 2033 年

美國腎臟去神經導管市場摘要

2025 年美國腎臟去神經導管市場價值估計為 2,320 萬美元，預計到 2033 年將達到 1.827 億美元，2025 年至 2033 年的複合年成長率為 29.43%。推動這一成長的因素包括高血壓盛行率的上升和人們對藥物治療局限性的認知的提高、越來越多的臨床證據支持腎臟核准的安全性和有效性，以及 FDA 最近批准等有利的監管發展，進一步加速了市場採用。

根據美國國家衛生統計中心和國家健康與營養檢查調查2024年10月發布的數據，2021年8月至2023年8月期間，美國成年人高血壓患病率在18-39歲人群中上升至23.4%，在40-59歲人群中上升至52.5%，在60歲及以上人群中達到71.6%。

高血壓的高發生率是美國腎臟去神經導管產業的主要驅動力之一。此外，越來越多的患者患有抗治療性高血壓，這種高血壓對多種抗高血壓藥物反應不佳。這種普遍存在的疾病負擔使得臨床對替代治療性介入（例如腎臟去神經導管）產生了強烈的需求，這種干預措施提供了一種非藥物的長期血壓控制方法。隨著認知度和診斷率的提高，預計適合接受腎臟去神經導管手術的患者群體將會增加，從而進一步推動市場需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國腎臟去神經導管市場變數、趨勢與範圍

• 市場體系展望
  • 補貼市場展望
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
  • 市場機會分析
  • 市場問題分析
• 美國腎臟去神經導管市場分析工具
  • 產業分析-波特五力分析
  • PESTEL分析

第4章美國腎臟去神經導管市場：產品估計與趨勢分析

• 細分儀表板
• 美國腎臟去神經導管市場的產品差異分析
• 美國腎臟去神經導管市場規模及趨勢分析（依產品，2025-2033）
• 射頻（RF）消融導管
• 超音波消融導管

第5章美國腎臟去神經導管市場：最終用途估計和趨勢分析

• 細分儀表板
• 美國腎臟去神經導管市場的最終用途差異分析
• 2025-2033年美國腎去神經導管市場規模及趨勢分析（依最終用途）
• 醫院
• 其他

第6章 競爭態勢

• 市場參與企業分類
• 主要企業簡介
  • Recor Medical, Inc.（Otsuka Medical Devices Co., Ltd.）
  • Medtronic
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • EnligHTN, St. Jude Medical（Abbott Laboratories）
  • Ablative Solutions, Inc.

U.S. Renal Denervation Catheter Market Summary

The U.S. renal denervation catheter market size was estimated at USD 23.20 million in 2025 and is projected to reach USD 182.70 million by 2033, growing at a CAGR of 29.43% from 2025 to 2033. The growth is driven by the rising prevalence of hypertension and growing awareness about the limitations of pharmacological treatments, increasing clinical evidence supporting the safety and efficacy of renal denervation, and favorable regulatory advancements, such as the recent FDA approval, are further accelerating market adoption.

According to data released by the National Center for Health Statistics and the National Health and Nutrition Examination Survey in October 2024, the prevalence of hypertension among U.S. adults was 23.4% for those aged 18-39, rising to 52.5% for individuals aged 40-59, and reaching 71.6% for those aged 60 and older during the period from August 2021 to August 2023.

The high prevalence of hypertension is one of the primary drivers for the U.S. renal denervation catheter industry. In addition, a growing subset of patients suffers from treatment-resistant hypertension, which does not respond adequately to multiple antihypertensive medications. This widespread burden of disease creates a strong clinical need for alternative therapeutic interventions, such as renal denervation, which offers a non-pharmacological approach to long-term blood pressure control. As awareness and diagnosis rates improve, the eligible patient pool for RDN procedures is expected to expand, further propelling market demand.

U.S. Renal Denervation Catheter Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2033. For this study, Grand View Research has segmented the U.S. renal denervation catheter market report based on product and end use:

• Product Outlook (Revenue, USD Million, 2025 - 2033)
• Radiofrequency (RF) Ablation Catheters
• Ultrasound Ablation Catheters
• End Use Outlook (Revenue, USD Million, 2025 - 2033)
• Hospitals
• Other

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
  • 1.5.5. Information Analysis
  • 1.5.6. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Renal Denervation Catheter Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of hypertension as a leading cause of cardiovascular disease
    • 3.2.1.2. Growing regulatory approvals
    • 3.2.1.3. Increasing awareness about hypertension management market restraint analysis
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Potential adverse events and complications associated with renal denervation catheters
    • 3.2.2.2. Shortage of cardiologists
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing clinical trials for renal denervation catheters
    • 3.2.3.2. Improving reimbursement for renal denervation catheters
    • 3.2.3.3. Strategic investments for renal denervation product portfolio expansion
    • 3.2.3.4. Advancing multielectrode RDN catheters with dual access capabilities
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Stringent regulations
• 3.3. U.S. Renal Denervation Catheter Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Renal Denervation Catheter Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Renal Denervation Catheter Market Product Movement Analysis
• 4.3. U.S. Renal Denervation Catheter Market Size & Trend Analysis, by Product, 2025 to 2033 (USD Million)
• 4.4. Radiofrequency (RF) Ablation Catheters
  • 4.4.1. Radiofrequency (RF) Ablation Catheters Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)
• 4.5. Ultrasound Ablation Catheters
  • 4.5.1. Ultrasound Ablation Catheters U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)

Chapter 5. U.S. Renal Denervation Catheter Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Renal Denervation Catheter Market End Use Movement Analysis
• 5.3. U.S. Renal Denervation Catheter Market Size & Trend Analysis, by End Use, 2025 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)
• 5.5. Other
  • 5.5.1. Other U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. Recor Medical, Inc. (Otsuka Medical Devices Co., Ltd.)
    • 6.2.1.1. Company Overview
    • 6.2.1.2. Financial Performance
    • 6.2.1.3. Product Benchmarking
    • 6.2.1.4. Strategic Initiatives
  • 6.2.2. Medtronic
    • 6.2.2.1. Company Overview
    • 6.2.2.2. Financial Performance
    • 6.2.2.3. Product Benchmarking
    • 6.2.2.4. Strategic Initiatives
  • 6.2.3. Boston Scientific Corporation
    • 6.2.3.1. Company Overview
    • 6.2.3.2. Financial Performance
    • 6.2.3.3. Product Benchmarking
    • 6.2.3.4. Strategic Initiatives
  • 6.2.4. MicroPort Scientific Corporation
    • 6.2.4.1. Company Overview
    • 6.2.4.2. Financial Performance
    • 6.2.4.3. Product Benchmarking
    • 6.2.4.4. Strategic Initiatives
  • 6.2.5. EnligHTN, St. Jude Medical (Abbott Laboratories)
    • 6.2.5.1. Company Overview
    • 6.2.5.2. Financial Performance
    • 6.2.5.3. Product Benchmarking
    • 6.2.5.4. Strategic Initiatives
  • 6.2.6. Ablative Solutions, Inc.
    • 6.2.6.1. Company Overview
    • 6.2.6.2. Financial Performance
    • 6.2.6.3. Product Benchmarking
    • 6.2.6.4. Strategic Initiatives

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. U.S. Renal Denervation Catheter Market, by Product, 2025 - 2033 (USD Million)
• Table 4. U.S. Renal Denervation Catheter Market, by End Use, 2025 - 2033 (USD Million)
• Table 5. Participant's Overview
• Table 6. Financial Performance
• Table 7. Product Benchmarking
• Table 8. Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Renal Denervation Catheter Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Regional Marketplace: Key Takeaways
• Fig. 13 U.S. Renal Denervation Catheter Market, for Product, 2025 - 2033 (USD Million)
• Fig. 14 U.S. Renal Denervation Catheter Market, for Radiofrequency (RF) Ablation Catheters, 2025 - 2033 (USD Million)
• Fig. 15 U.S. Renal Denervation Catheter Market, for Ultrasound Ablation Catheters, 2025 - 2033 (USD Million)
• Fig. 16 U.S. Renal Denervation Catheter Market, for End Use, 2025 - 2033 (USD Million)
• Fig. 17 U.S. Renal Denervation Catheter Market, for Hospitals, 2025 - 2033 (USD Million)
• Fig. 18 U.S. Renal Denervation Catheter Market, for Other, 2025 - 2033 (USD Million)